Non-Mechanized Exercise Training to Improve Pain Free Walking Distance in Patients with Peripheral Artery Occlusion by Suganya, M
NON-MECHANIZED EXERCISE TRAINING TO IMPROVE PAIN 
FREE WALKING DISTANCE IN PATIENTS WITH PERIPHERAL 
ARTERY OCCLUSION 
 
Dissertation submitted in 
the Partial fulfillment 
for the degree of 
MASTER OF PHYSIOTHERAPY 
             (CARDIO RESPIRATORY)  
The Tamil Nadu Dr. M.G.R. Medical University 
   Chennai  
 
 
 
 
 
May 2018 
 
 
PSG COLLEGE OF PHYSIOTHERAPY 
Coimbatore 
PSG COLLEGE OF PHYSIOTHERAPY 
Coimbatore 
 
CERTIFICATE 
  
This is to certify that the research work entitled “NON MECHANIZED 
EXERCISE TRAINING TO IMPROVE PAIN FREE WALKING DISTANCE 
IN PATIENTS WITH PERIPHERAL ARTERY OCCLUSION” was carried 
out by Reg. No. 271630241, of P.S.G. College of Physiotherapy, towards the  
partial fulfillment for the degree of MASTER OF PHYSIOTHERAPY 
(Physiotherapy in Cardio Respiratory) affiliated to The TamilNadu Dr. M.G.R. 
Medical University, Chennai. 
 
 
Internal Examiner      External Examiner 
 
Date of Evaluation: 
  
PSG COLLEGE OF PHYSIOTHERAPY 
Coimbatore 
 
CERTIFICATE 
 
This is to certify that the dissertation work entitled “NON MECHANIZED 
EXERCISE TRAINING TO IMPROVE PAIN FREE WALKING 
DISTANCE IN PATIENTS WITH PERIPHERAL ARTERY OCCLUSION” 
was carried out by  Reg. No. 271630241 of P.S.G. College of Physiotherapy, 
Coimbatore, affiliated to The TamilNadu Dr. M.G.R. Medical University, Chennai. 
 
 
Prof. R. MAHESH, MPT., 
Principal 
P.S.G. College of Physiotherapy 
Coimbatore - 641 004. 
 
Place: Coimbatore 
Date: 
  
PSG COLLEGE OF PHYSIOTHERAPY 
Coimbatore 
 
CERTIFICATE 
 
This is to certify that the dissertation work entitled “NON MECHANIZED 
EXERCISE TRAINING TO IMPROVE PAIN FREE WALKING 
DISTANCE IN PATIENTS WITH PERIPHERAL ARTERY OCCLUSION” 
was carried out by, SUGANYA.M, Reg. No. 271630241 of  P.S.G. College of 
Physiotherapy, Coimbatore, affiliated to The TamilNadu Dr. M.G.R. Medical 
University, Chennai, under our guidance. 
 
 
 
 
Guide              Co-Guide 
Prof. R. MAHESH, MPT.,                 Mr. M. Mahendiran, MPT., 
Principal          Clinical Physio Specialist, Grade-II 
P.S.G. College of Physiotherapy           P.S.G. College of Physiotherapy 
Coimbatore - 641 004.                             Coimbatore - 641 004. 
  
 
 
 
Place: Coimbatore 
Date: 
PSG COLLEGE OF PHYSIOTHERAPY 
Coimbatore 
 
CERTIFICATE 
 
 This is to certify that the research work entitled “NON MECHANIZED 
EXERCISE TRAINING TO IMPROVE PAIN FREE WALKING DISTANCE 
IN PATIENTS WITH PERIPHERAL ARTERY OCCLUSION” was carried 
out by SUGANYA .M, Reg. No. 271630241 of P.S.G. College of Physiotherapy, 
towards the partial fulfillment for the degree of MASTER OF 
PHYSIOTHERAPY (Physiotherapy in Cardio Respiratory) affiliated to The 
TamilNadu Dr. M.G.R. Medical University, Chennai, under my guidance. 
 
 
 
 
Dr. P.R. MURUGESAN, MD.,DNB.,M.CH.,DNB., 
              Professor & HOD 
Department of Cardio thoracic and vascular surgery 
PSG Hospitals 
Coimbatore-641 004. 
Place: Coimbatore       
Date: 
  
ACKNOWLEDGEMENT 
I would like to express my deepest appreciation to the ALMIGHTY for 
showering his blessings, who has always been my source of strength and who 
guides me throughout. 
I would like to be dedicate first and devote my heartfelt thanks to my ever 
loving Parents and sister for their indescribable love and support throughout my 
carrier. 
I would like to express my sincere gratitude to my project guide                                
Prof. R. MAHESH, Principal, PSG College of Physiotherapy, Coimbatore, for his 
guidance, patience, sharing his knowledge, innovations and  continuous motivation 
throughout the study and enabling me to complete the dissertation successfully.  
I am very grateful to Dr.P.R Murugesan, Professor and Head of the 
Department of Cardio thoracic and vascular surgery, PSG Hospitals for his 
constant motivation and unwavering encouragement by rendered his invaluable 
experience and guidance to this project. 
I am deeply indebted to Ms. P. Shanmugapriya , for her insight comments 
and who helped me to initiate this research through collegial guidance.  
My heartfelt thanks to Mr. M. Mahendiran, for his great support, 
motivation in this research and sharing his wide knowledge and the incredible 
experiences of his career. 
My special thanks to Mrs. V. Mahalakshmi, Post Graduate Incharge, who 
has guided me and motivated and helped me throughout my academic activities 
and dissertation completion. 
My Sincere thanks to Mr. Saravanan, Mr. Raja Regan, Mr. Nagaraj,            
Mrs. Sweety Subha, , and Mrs. Malarvizhi for their valuable suggestions during 
the presentations. 
I am grateful to Dr. Anil Mathew, Ph.D, Associate Professor, Department 
of Biostatistics, PSG Institute of Medical Science and Research who helped me in 
statistical method of data analysis. 
I express my gratitude to Mrs. Ashraf. Y, and also  thank the  members of 
Institutional Review Committee of Research, College of Physiotherapy and 
Human Ethics Committee of PSG Institute of Medical Science and Research for 
their valuable suggestions to complete the dissertation. 
A special word of gratitude to Ms. V. Bhuvaneshwari ,who boosted me up 
in the field of Physiotherapy with his valuable suggestions. 
I extend my sincere thanks to Dr. Vaishnavi, Dr. Preethi, and for their 
support and constructive feedbacks who helped during preparation of my thesis 
work. 
My lovable thanks to my friend Ms. Saranya for her love, caring and 
valuable suggestions throughout my carrier. 
My special thanks and appreciation to all my esteemed Friends, Colleagues, 
Seniors & Juniors for sharing their knowledge, love, support and exclusive 
cooperation. 
 
 
My special thanks to Senior librarian and Mr.Sudhagar, Mr.Nandha 
Kumar,  Mrs. Jamuna Rani, Mrs. Rajeshwari staffs of library and Mrs.Sarojini. M 
& Mrs. Seetha Lakshmi secretary of  PSG  Hospital for their great support, helping 
me to complete this project successfully.  
Finally, I thank all the Patients for their kind co-operation. Without their 
involvement this project would have not been possible.   
  
ABBREVIATIONS 
 
PAD     - Peripheral Artery Disease. 
IC                      -        Intermittent Claudication 
ABI   - Ankle Brachial Index 
6MWT  - Six Minute Walk Test 
WIQ              - Walking Impairment Questionnaire  
  
  
CONTENTS 
CHAPTER                        TITLE     PAGE NO 
 I  INTRODUCTION        1 
   1.1 Need for the Study       2 
  1.2 Objective        2 
  1.3  Hypothesis        2  
  1.4 Operational Definitions      3 
1.5 Projected Outcome       3 
II  REVIEW OF LITERATURE      4 
III  MATERIALS AND METHODOLOGY     8 
3.1 Materials        8 
3.2 Study Design        8 
3.3 Study Setting        9 
3.4       Study duration       9 
3.5 Human Participation Protection     9 
3.6 Sampling        9 
3.7 Treatment duration       9 
3.8 Criteria for Sample Selection      9 
   3.8.1 Inclusion Criteria      9 
3.8.2 Exclusion Criteria      10 
3.9 Technique of Data Collection      10 
IV  STATISTICAL ANALYSIS AND INTERPRETATION   12 
V  RESULTS AND DISCUSSION      25 
   5.1 Limitations        28 
   5.2 Recommendations       28 
VI  SUMMARY AND CONCLUSION      29 
  BIBLIOGRAPHY        30 
  ANNEXURE          
ABSTRACT  
  
LIST OF ANNEXURES 
 
   Annexure       Content 
 
 I Ethical Committee Clearance Letter 
 II Assessment Form and Proforma  
 III Informed Consent (English and Tamil) 
 IV Outcome measures 
 V Treatment protocol 
VI Data table 
 
1 
 
 CHAPTER-I 
INTRODUCTION 
Peripheral artery disease (PAD) is also called as Peripheral artery occlusive disease 
(PAOD) is the most commonly defined as gradual obstruction of arteries leading to impaired 
blood flow
(1)
. 
The risk of developing PAD can be predicted by the patient‘s age and well-defined 
atherosclerotic risk factors, including cigarette smoking, dyslipidemia, diabetes mellitus, and 
arterial hypertension
(2)
.  
It is common in diabetic and in chain smokers. The prevalence of PAD in diabetic 
patients was found to be 3.2% in a study from south India and as high as 15.9% in a western 
population
(3)
.It can be increase with ageing, in general population it accounts for 12% to 14% 
affecting up to 25% of subjects over 75 years
(2)
. 
Intermittent Claudication (IC), which is defined as a reproducible lower extremity 
muscular pain induced by exercise and relieved by rest
(2)
.Superficial femoral and popliteal 
arteries are most commonly affected by atherosclerotic plaques. As plaques grow they reduce 
blood flow through, to the tissues distal to the obstruction, ischemia to the muscles are 
accompanied by sensation of the local muscle pain which is increased during periods of 
increased oxygen consumption (Vo2) such as during exercise
(2)
. 
FONTAINE‟S CLASSIFICATION (8) : 
STAGE CLINICAL SYMPTOMS 
Stage 1 Asymptomatic 
Stage 2 a Pain with walking more than 200 meters 
Stage 2 b Pain with walking less than 200 meters 
Stage 3 Rest pain 
Stage 4 Necrosis or gangrene of the lower limb 
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      Non-mechanized exercise training is a form of exercise programme without the use of any 
mechanical equipments like Treadmill, bicycle ergometry which helps to improve blood flow 
in the peripheral arteries of lower extremities. 
1.1 NEED FOR THE STUDY 
PAD is a condition leading to increased morbidity and mortality rate in males with 
smoking history who present with decreased walking ability and functional status. This study 
mainly focuses on justifying the effects of non-mechanized exercise training in improving 
peripheral blood circulation and pain free walking distance in patients with peripheral artery 
occlusive disease. 
Due to increased prevalence of PAD, evaluating and implementing different types of 
rehabilitation through equipments are available. So, the primary goal of this study is to train 
with activity as exercise in home based set up without the use of machines that promote a 
better health related quality of life in patients by  
 Decreasing claudication  pain. 
 Improving pain free walking distance. 
1.2 OBJECTIVE 
To find out the effects of non-mechanized exercise training in improving pain free 
walking distance in patients with peripheral artery occlusion.  
1.3 HYPOTHESIS 
Null hypothesis: 
There is no significant difference in pain free walking distance in patients with 
peripheral artery occlusion after a non-mechanized exercise training programme. 
Alternative hypothesis: 
There is significant difference in pain free walking distance in patients with peripheral 
artery occlusion after a non-mechanized exercise training   programme. 
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1.4 OPERATIONAL DEFINITIONS 
Peripheral Arterial Disease (PAD) 
Peripheral arterial disease is characterized by the development of obstructive 
atherosclerotic plaques in the arteries of peripheral limbs
 (1)
. 
Intermittent Claudication (IC) 
          The term ―claudication‖ comes from Latin, where claudiactio means ―limping‖. 
Intermittent claudication is the pain in the lower limbs during walking, which forces the 
person to stop walking
(7)
.   
Non-mechanized exercise training 
Non-mechanized exercise training is a form of exercise programme without using any 
mechanical  equipments helping to improve blood flow in the peripheral arteries of the lower 
extremities. 
Pain Free Walking Distance  
         The distance that a person with Peripheral arterial disease can walk before the 
claudication pain begins. 
1.5 PROJECTED OUTCOME 
Based on the literature review, it is expected that the result of the study will be 
clinically significant and there is be a significant difference in pain free walking distance. 
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CHAPTER-II 
REVIEW OF LITERATURE 
 Maria Szymczak, Marian Majchrzycki, et al (2014) conducted the most common form 
of rehabilitation of patients with PAD is unassisted treadmill training in a home 
environment or assisted treadmill training. Alternative options include strength exercises 
of the lower limbs, osteopathic techniques, stationary bike exercises or the combination of 
the mentioned methods. The alternative methods of rehabilitation have a positive effect on 
PAD patients; however, their efficacy has been studied only recently. Currently, treadmill 
training is the most effective, evidence-based, form of rehabilitation of patients with IC. 
 
  Fokkenrood   Bendermacher   BLW, et al (2013) total of 14 studies involving a total of 
1002 participant with PAD were included in this review. Follow-up ranged from six 
weeks to 12 months. In general, supervised exercise regimens consisted of three exercise 
sessions per week. All trials used a treadmill walking test as one of the outcome measures. 
The overall quality of the included trials was moderate to good, although some trials were 
small with respect to the number of participants, ranging from 20 to 304. Supervised 
exercise therapy (SET) showed statistically significant improvement in maximal treadmill 
walking distance compared with non-supervised exercise therapy regimens, with an 
overall effect size of 0.69 (95% confidence interval (CI) 0.51 to 0.86) and 0.48 (95% CI 
0.32 to 0.64) at three and six months, respectively.This translates to an increase in 
walking distance of approximately 180 meters that favoured the supervised group. SET 
was still beneficial for maximal and pain-free walking distances at 12 months, but it did 
not have a significant effect on quality of life parameters concluded SET has statistically 
significant benefit on treadmill walking distance (maximal and pain-free) compared with 
non-supervised regimens. However, the clinical relevance of this has not been 
demonstrated definitively; additional studies are required that focus on quality of life or 
other disease-specific functional outcomes, such as walking behaviour, patient 
satisfaction, costs, and long-term follow-up. Professionals in the vascular field should 
make SET available for all patients with IC. 
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 Atul Jain, MD, Kiang Liu, et al (2012) 1048 men and women with and without PAD 
were identified from Chicago-area medical centers. Participants completed the WIQ at 
baseline and were followed for a median of 4.5 years. Cox proportional hazards models 
were used to relate baseline WIQ scores with mortality, adjusting for age, sex, race, the 
ankle brachial index (ABI), co-morbidities, and other covariates. Results- 461 participants 
(44.0%) died during follow-up, including 158 deaths from cardiovascular disease. PAD 
participants in the lowest baseline quartile of the WIQ stair-climbing scores had higher 
all-cause mortality (HR = 1.70 [95% Confidence Interval (CI) 1.08-2.66, p=0.02] and 
higher CVD mortality (HR = 3.11 [95% CI 1.30 – 7.47, p=0.01]) compared to those with 
the highest baseline WIQ stair climbing score. Among PAD participants there were no 
significant associations of lower baseline WIQ distance or speed scores with rates of all-
cause mortality (p for trend = 0.20 and 0.07, respectively) or  CVD  mortality (p for trend 
= 0.51 and p for trend = 0.33, respectively). Among non-PAD participants there were no 
significant associations of lower baseline WIQ stair climbing, distance, or speed score 
with rates of all-cause mortality (p for trend = 0.94, 0.69, and 0.26, respectively) or CVD 
mortality (p for trend = 0.28, 0.68, and 0.78 respectively). finally, author Concluded 
Among participants with PAD, lower WIQ stair climbing scores are associated with 
higher all-cause and CVD mortality, independently of the ABI and other covariates. 
 
 Naomi M. Hamburg, MD et al (2011) Reviewed 22 studies with > 1200 participants 
conducted by the coherence group in 2008 compared supervised programs with usual care 
in treatment of claudication. The American heart association/American association of 
cardio vascular and pulmonary rehabilitation core components of cardiac rehabilitation 
secondary prevention programs outline the comprehensive nature of such programs with 
goal of reducing physical disability and cardiovascular risk while restoring optimal 
physical, psychological, and social functioning. such programs integrate exercise into the 
overall treatment plan that includes lipid management, blood pressure control, smoking 
cessation, nutrition education, and weight reduction, diabetes mellitus treatment and 
psycho social intervention with the use of this multifaceted approach, cardiac 
rehabilitation/secondary prevention programs have been associated up to a 56% 
improvement in survival among patients after myocardial infarction and a 28% reduction 
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in the risk of recurrent myocardial infarction. Such benefits are seen despite age gender 
and ethnic back ground. Furthermore benefits of such programs appear to be dose related 
in patients who attend 36 sessions have a 14%,22% and 47% lower risk of mortality than 
those who attend 24 sessions,12 sessions and 1 session respectively. However, no study 
has yet been conducted to evaluate the effect of exercise rehabilitation in PAD patients on 
mortality. 
 
 Andrew W. Gardner, et al., 2011) randomized 119 patients and concluded that 29 
patients completed home-based exercise, 33 completed supervised exercise and 30 
completed usual care control as secondary prevention. Both exercise programs consisted 
of intermittent walking to near maximal claudication pain for 12 weeks. Patients wore a 
step activity monitor during each exercise session. Primary outcome measures included 
claudication onset time (COT) and peak walking time (PWT) obtained from a treadmill 
exercise test, and secondary outcome measures included daily ambulatory cadences 
measured during a 7-day monitoring period. Home-based exercise appears more 
efficacious in increasing daily ambulatory activity in the community setting than 
supervised exercise. 
 
  J.C. Tsai et al., (2002) conducted prospective randomized control trial on 64 patients. 
Thirty two of 64 patients with fontaine stage 2 peripheral arterial occlusive disease 
(PAOD) were randomized to exercise training and 32 to usual care control. Results shows 
that the compliance of exercise programme was 83% of possible sessions. Exercise 
training increased treadmill walking time to onset of cladication pain by 88% (P <0.001), 
time to maximal pain by 70%(P <0.001), and six minute walk distance by 21% %(P 
<0.001). 
 
 Mary MeGrace, Mc Dermott et al., (1999) conducted cross sectional study in  RCT 147 
Participants were analyses patients with atypical exertional leg symptoms IC pain at rest 
respectively had poorer scores for walking distance, walking speed and stair climbing. 
Among PAD patients only pain at rest was associated independently with WIQ scores and 
SF 36 domains with ABI was independent predictor of WIQ distance scores. Results 
showed Both PAD related leg symptoms ABI Predict patient received walking ability in 
PAD.   
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 Judith G. Regensteiner, et al., (1994) conducted RCT 29 men with disabling IC were 
randomized to 12 weeks of either supervised treadmill training 3hr/wk at a work intensity 
sufficient to produce claudication, strength training (3hr/wk of resistive training of 6 
muscle groups of each legs or to non-exercising control group. After 12 weeks of 
treadmill training PAR (Physical Activity Recall) scores increased by 48 metabolic 
equivalent hr/wk, medical outcome measures (MOS) Physical Functioning Score by 24 
Percentage points and the number of bouts of walking activity measured by vitalog by 4.5 
bouts/hr (all p< 0.05).A Supervised treadmill training program improved functional status 
during daily activities with 24 weeks more effective than 12 weeks. In addition, treadmill 
training alone was more effective in improving functional status in patients with IC than 
strength training or combinations of the training modalities. 
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CHAPTER-III 
MATERIALS AND METHODOLOGY 
3.1 MATERIALS 
A. Tools used for measuring 6 MWT 
 Pulse oximeter 
 Sphygmomanometer 
 Stop watch 
 Cones 
B. Tools used for measuring ABI 
 Sphygmomanometer with appropriately sized cuff(s) for both arm and ankle. 
 Handheld Doppler device with vascular probe. 
 Conductivity gel compatible with Doppler device. 
3.2 STUDY DESIGN 
A QUASI EXPERIMENTAL STUDY DESIGN: (Pre-test and post-test design with 
treatment comparison)   
Quasi Experimental Study Design is adopted for the study. With the help of this study 
design, the pre-test and post-test values are assessed for Group-A & Group-B. 
In my study, the pre-test measurement of ABI, 6MWT and WIQ scores were measured 
before starting medications and the routine management (conventional  management) for 
Group-A or  medications along with the non-mechanized exercise training  that is structured  
for Group-B. The post-test ABI, 6MWT pain free walking distance and WIQ scores were 
measured after the 12 weeks of home-based exercise. 
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3.3 STUDY SETTING 
Department of  Cardio thoracic and Vascular Surgery, P.S.G Hospitals, Coimbatore. 
3.4 STUDY DURATION 
Duration of 8 months was adopted for this study. 
3.5 HUMAN PARTICIPATION PROTECTION 
The study was reviewed and approved by institutional human ethics committee of PSG IMSR. 
3.6 SAMPLING 
A total of  20 patients were selected by Simple Random Sampling.  
Group-A: 10 patients received medications along with routine management (conventional 
management) 
Group-B: 10 patients received medications along with the non-mechanized exercise training 
Programme that is structured.  
3.7 TREATMENT DURATION 
Group-A: Medications along with routine management (conventional management) 
continued for 12 weeks. 
Group-B: Medications along with the non-mechanized exercise training for 1 session per 
day, thrice weekly for 12 weeks. 
3.8 CRITERIA FOR SAMPLE SELECTION 
3.8.1 Inclusion Criteria 
 Age above 40 to 65 years. 
 Subjects with fontaine stage 2(Intermittent Claudication  pain) & fontaine stage 3 
(nocturnal pain). 
 Unilateral Peripheral artery occlusion. 
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3.8.2 Exclusion Criteria 
 History of exertional angina. 
 Exercise tolerance limited by leg pain due to non-vascular origin (e.g. arthritis, 
orthopedic pain). 
 Myocardial infarction with in the preceding 3 months. 
 Surgery related to PAOD during the preceding 3 months. 
 Lower extremity ulcers. 
3.9 TECHNIQUE OF DATA COLLECTION 
 In Group-A ABI, 6MWT distance and WIQ scores were measured before starting, the 
review was done  on the  6
th
 week to follow up or any changes( improvement) 
clarification in the exercise programme and end of the 12
th
 week. 
 In Group-B ABI, 6MWT distance and WIQ scores were measured before starting, the 
review was done  on the  6
th
 week to follow up or any changes( improvement) 
clarification in the exercise programme  and 6th week and end of the 12th week. 
 Peripheral Artery occlusion  classification was done using fontaine classification  
stage 2 & stage 3. 
 Walking speed, and distance were measured using WIQ. 
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METHODOLOGY FLOW CHART 
Patients with Peripheral artery 
occlusion 
 
Patient selection based on  
(inclusion & exclusion criteria) 
 
 
 
Obtain Consent 
form 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Group allocation 
(simple Random Sampling) 
Group B  
[Medications with Non Mechanized 
Exercise Training] 
n=10 
Group A  
[Medications with Routine 
hospital based training] 
n=10 
Pre treatment assessment 
Measurement tools  
 Ankle Brachial index, 
 Walking impairment questionnairre, 
 Six minute walk test. 
Each individual will receive 12 weeks Home based treatment sessions (1 
sessions /day , 3 days a week for 12 weeks) 
Post treatment assessment 
(Same measurement tools used) 
Data Analysis 
Results 
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CHAPTER-IV 
STATISTICAL ANALYSIS AND INTERPRETATION 
A total of 20 patients were selected by Simple Random sampling method. 10 
participants were randomly selected and assigned to Group-A and Group-B. 
Group-A: 10 patients received medications along with routine management (conventional 
management)  
Group-B: 10 patients received medications along with the non-mechanized exercise training 
that is structured. 
The pre-test and post-test values were taken for interpretation of Degree of walking 
difficulty, Pain free walking distance and classification of artery occlusion with the WIQ, 
6MWT pain free walking distance and ABI respectively. The mean, standard deviation and 
Paired ‗t‘ test is used to find out whether there is any significant difference between pre-test 
and post-test values within the groups. 
Independent  ‗t‘ test, mean difference values for ABI, 6MWT and WIQ of Group-A 
and Group-B were used to find out whether there is any significant difference between  the 
two  groups. 
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TABLE-1 
PAIRED „t‟ TEST VALUES OF ANKLE BRACHIAL INDEX–GROUP A& GROUP B 
(n=20) 
Groups Mean Mean 
Difference 
Standard 
Deviation 
„t‟ Value „p‟ Value 
Group A 
Pre-test 
Post-test 
 
0.624 
0.841 
 
0.217 
 
0.079 
 
8.714 
 
p<0.05 
Group B 
Pre-test 
Post-test 
 
0.633 
0.941 
 
0.308 
 
0.096 
 
10.145 
 
p<0.05 
 
 
Based on Table-1, the mean difference of Group-A is found to be 0.217, Standard 
deviation is 0.079, the ‗t‘ value using the paired ‗t‘ test is 8.714 which is greater than the table 
value of  2.262 at p<0.05. In Group-B the mean difference is 0.308, Standard deviation is 
0.096, the ‗t‘ value using the paired ‗t‘ test is 10.145 which is greater than the table value of 
2.262 at p<0.05. This shows there is a significant in ABI values in both groups. The result 
shows that pre-test and post-test mean difference of ABI values of Group-B is statistically 
significant than Group-A. 
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TABLE-2 
PAIRED „t‟ TEST VALUES OF 6MWT (PAIN FREE WALKING DISTANCE) 
GROUP A & GROUP B 
(n=20) 
Groups Mean Mean 
Difference 
Standard 
Deviation 
„t‟ Value „p‟ Value 
Group A 
Pre-test 
Post-test 
 
130.50 
190.50 
 
60 
 
41.633 
 
4.557 
 
p<0.05 
 
Group B 
Pre-test 
Post-test 
 
145.00 
265.50 
 
120.50 
 
 
55.899 
 
6.817 
 
p<0.05 
 
Based on Table-2, the mean difference of Group-A is found to be 60, Standard 
deviation is 41.633, the ‗t‘ value using the paired ‗t‘ test is 4.557 which is greater than the 
table value of 2.262 at p>0.05. In Group-B the mean difference is 120.50, Standard deviation 
is 55.899, the ‗t‘ value using the paired ‗t‘ test is 6.817 which is greater than the table value of 
2.262 at p<0.05. This shows there is a significant improvement in Group-A & Group-B 
6MWT Pain free walking distance. This result shows that pre-test and post-test mean 
difference of 6MWT Pain free walking distance of Group-B is statistically significant than 
Group-A. 
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TABLE-3 
PAIRED  „t‟ TEST VALUES OF WIQ SCORES- GROUP A & GROUP B 
(n=20) 
Groups Mean Mean 
Difference 
Standard 
Deviation 
„t‟ Value „p‟ Value 
Group A 
Pre-test 
Post-test 
 
24.30 
32.50 
 
6.2 
 
3.583 
 
7.235 
 
p<0.05 
Group B 
Pre-test 
Post-test 
 
23.60 
46.40 
 
22.8 
 
8.093 
 
8.908 
 
p<0.05 
 
Based on Table 3, the mean difference of Group-A is found to be 6.2, Standard 
deviation is 3.583, the ‗t‘ value using the paired ‗t‘ test is 7.235 which is greater than the table 
value of 2.262 at p<0.05. In Group-B the mean difference is 22.8, Standard deviation is 8.093, 
the ‗t‘ value using the paired ‗t‘ test is 8.908 which is greater than the table value of 2.262 at 
p<0.05. This shows there is a significant improvement in WIQ scores in both groups. The 
result shows that pre-test and post-test mean difference of WIQ scores Group-B is statistically 
significant than Group-A. 
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GRAPH-1 
PRE TEST AND POST TEST MEAN VALUES FOR ABI OF GROUP A 
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GRAPH-2 
PRE TEST AND POST TEST MEAN VALUES FOR 6MWT (PAIN FREE 
WALKING DISTANCE)& WIQ OF GROUP A  
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GRAPH-3 
PRE TEST AND POST TEST MEAN VALUES FOR ABI OF GROUP B  
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GRAPH-4 
PRE TEST AND POST TEST MEAN VALUES FOR 6MWT (PAIN FREE 
WALKING DISTANCE) & WIQ OF GROUP B  
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TABLE-4 
INDEPENDENT „t‟ TEST VALUES OF GROUP A & GROUP B 
Outcome Measures Mean 
Mean 
Difference 
Standard 
Deviation  
„t‟ value „p‟ value 
ABI 
A 0.841 
0.941 
 
 
1.00 0.027 7.368 p<0.05 
B  
6MWT 
A 190.50 
 
265.50 
 
75.00 51.50 
 
2.097 p>0.05 
B  
WIQ 
A 32.50 
 
46.40 
13.90 
5.378 5.284 p<0.05 
B  
 
The independent ‗t‘ test is performed between the Group-A and Group-B to analyze 
the significance of routine management(conventional management) and non-mechanized 
exercise training on improving pain free walking distance in PAD patients. 
For ABI, between the groups the calculated ‗t‘ value is 7.368 which is greater than the 
table value of 2.101 at p<0.05. For 6 MWT pain free walking distance, between the groups 
the calculated ‗t‘ value is 2.097 which is less than the table value of 2.101 at p<0.05. For 
WIQ, between the groups the calculated ‗t‘ value is 5.284 which is greater than the table value 
of 2.101 at p<0.05. Therefore, the statistical analysis showed that there is a significant 
improvement in ABI& WIQ and statistically there is no significant improvement in 6 MWT 
pain free walking distance. 
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GRAPH-5 
POST MEAN VALUES FOR ANKLE BRACHIAL INDEX OF  
GROUP A & GROUP B 
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GRAPH-6 
POST MEAN VALUES FOR 6 MWT (PAIN FREE WALKING 
DISTANCE) OF GROUP A & GROUP B 
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GRAPH-7 
POST MEAN VALUES FOR  WIQ OF GROUP A & GROUP B 
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CHAPTER-V 
RESULTS AND DISCUSSION 
Patients with IC have an impact on their walking ability that may limit their function 
to meet the personal or social demands of daily living.In our study the aim is to improve the 
pain free walking distance in patients with PAD. 
Andrew C Bulmer et. al, (2004) Since 1960‘s numerous studies have identified 
training induced performance effects in patients with PAD and have progressed from using 
traditional walking training.  
A  total of 20 participants in age group of 40 to 65 years of PAD was taken for this 
study. The participants were randomly assigned into two groups. Measurements were taken at 
base line using Ankle Brachial Index, Walking Impairment Questionnaire for degree of 
difficulty in walking, Six Minute walk test  for calculating the  pain free walking distance and 
total distance. 
Casillas Jm et al., (2011) 6MWT is an equally important diagnostic tool evaluating the 
capacity of peripheral arteries in the lower extremities rehabilitation in patients with 
peripheral artery disease.  
In WIQ, it measures walking distance, speed, and stair climbing.Group-A received 
medications along with routine management (conventional management) Group-B received 
medications  along with non-mechanized exercise training programme which is structured. 
 J.c.tsai et.al suggested that two different mechanisms appear to explain the exercise 
mediated in walking function. improvements in walking economy and calf perfusion are two 
mechanism that act synergistically to relieve claudication by decreasing the metabolic 
demands of walking and increasing oxygen delivery. 
Paired t test values for ankle brachial index, the mean difference of Group-A is found 
to be 0.217, Standard deviation is 0.079, the ‗t‘ value using the paired ‗t‘ test is 8.714 which is 
greater than the table value of 2.262  at p<0.05. In Group-B the mean difference is 0.308, 
Standard deviation is 0.096, the ‗t‘ value using the paired ‗t‘ test is 10.145 which is greater 
26 
 
than the table value of 2.262 at p<0.05. This shows there is significant in Ankle brachial index 
values in both groups. The result shows that pre-test and post-test mean difference of Ankle 
brachial index values of Group-B is statistically significant than Group-A. In 6 MWT Pain 
free walking distance the mean difference of Group-A is found to be 60, Standard deviation is 
41.633, the ‗t‘ value using the paired ‗t‘ test is 4.557 which is greater than the table value of 
2.262 at p>0.05. In Group-B the mean difference is 120.50, Standard deviation is 55.89, the 
‗t‘ value using the paired ‗t‘ test is 6.817 which is greater than the table value of 2.262 at 
p<0.05. This shows there is significant improvement in 6MWT pain free walking distance in 
Group-A &Group-B. This result shows that pre-test and post-test mean difference of 6MWT 
pain free walking distance of Group-B is statistically significant than Group-A. In WIQ the 
mean difference of Group-A is found to be 6.2, Standard deviation is 3.583, the ‗t‘ value 
using the paired ‗t‘ test is 7.235 which is greater than the table value of 2.262 at p<0.05. In 
Group-B the mean difference is 22.8, Standard deviation is 8.093, the ‗t‘ value using the 
paired ‗t‘ test is 8.908 which is greater than the table value of 2.262 at p<0.05. This shows 
there is  significant improvement in WIQ scores in both groups. The result shows that pretest 
and posttest mean difference of WIQ scores Group-B is statistically significant than                
Group-A. 
The independent  ‗t‘ test is performed between Group-A and Group-B to analyze the 
significance of routine management  (conventional management) and non-mechanized 
exercise training on improving pain free walking distance in PAD patients. For ABI, between 
the groups the calculated ‗t‘ value is 7.368 which is greater than the table value of 2.101 at 
p<0.05. For 6 MWT pain free walking distance, between the groups the calculated ‗t‘ value is 
2.097 which is less than the table value of 2.101 at p<0.05. For WIQ, between the groups the 
calculated ‗t‘ value is 5.284 which is greater than the table value of 2.101 at p<0.05. 
Therefore the statistical analysis showed that there is a significant improvement in ABI, WIQ 
and there is no significant improvement in 6 MWT pain free walking distance. 
Judith G. Regensteiner et.al (2002)  states that walking ability can be reduced due to 
patients did not change their medication use or smoking status during the course of the study. 
Some patients are mostly depressed due to prolonged duration of the intolerable 
claudication pain it forces the person to stop walking. 
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Exercise training health related quality of life as assessed by medical outcome SF-36. 
We are not assessed psychological aspect of the patient. It may interfere with walking. For  6 
MWT pain free walking distance there is significant improvement in total distance. 
participants did not understand the claudication pain or could not tell the therapist during 
walking.Due to lack of communication, we can assess the individual difference because some 
participants did not have smoking history, dyslipidemia and hypertension. 
Mc.dermott.et.al (1999)stated that previous studies of patients with IC have shown 
inconsistent results regarding the ability of ABI. 
From my study there is a difficulty with the participants those who are illiterate were 
not clearly understood the clear pathology of the disease and exercise effects.  
          Schefifler et.al  suggested that supervised exercise training in treadmill increase pain 
free walking distance which improves walking ability over the 4
th 
week. In future the study 
can be done with 4 weeks of duration to see the immediate effects of non mechanized exercise 
training under supervision. 
 In my study majority of patients were 45-55 years and male : female ratios were 
approximately 9:1 . one explanation for this discrepancy in male : female ratios may be higher 
prevalence rates for PAD in men with symptomatic claudication more likely to obtain medical 
attention than woman. 
There is statistically significant improvement in ABI and WIQ when comparing two 
groups and  there is no significant changes in 6MWT pain free walking distance in patients 
with peripheral artery occlusion following Non-mechanized exercise training than 
conventional training. 
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5.1 LIMITATIONS 
 
 Very Small sample size based on   low outpatients census during the period of the 
study. 
  There is a difficulty with the participants those who are illiterate were not clearly 
understood the clear pathology of the disease and exercise effects. 
 Many participants were prone to peripheral artery surgery for immediate pain 
relief because some patient may had poor pain tolerance. 
 Male: female ratio is 9: 1. Variations may be interfering with the effect of the 
study, may be higher prevalence rate for PAD in men when compare to female. 
 Patients with risk factors like diabetic, dyslipidemia and  hypertension are  also 
included in this study. 
 
5.2 RECOMMENDATIONS 
 Large sample size can be taken for the effectiveness of the study.  
 The study can be done with bilateral PAD patients to assess the degree of 
difficulty 
 The study could be segregated with either superficial femoral or popliteal artery 
occlusion to assess the percentage of the artery occlusion. 
 We advise the exercise protocols for the PAD related risk factors for the 
preventive measures. 
 In future we can correlate the different age groups of the patients with PAD.  
 In future we can see the individual difference for the study.  
 In this study we are not included the intermediate test values for statistical 
analysis. We can include the intermediate test for the statistical analysis.    
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CHAPTER-VI 
SUMMARY AND CONCLUSION 
This study is conducted to analyses the effects of Non-mechanized exercise training to 
improve pain free walking distance in patients with peripheral artery occlusion in home-based 
patients. Thus, the statistical analysis of data concluded that  
“There is statistically significant improvement in ABI and WIQ when comparing 
two groups and  there is no significant changes in 6MWT pain free walking distance in 
patients with peripheral artery occlusion following Non-mechanized exercise training 
than conventional training.” 
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ANNEXURE I 
 
  
 
       ANNEXURE II 
Assessment Form 
DEMOGRAPHIC DATA 
Name   :      OP No  :                                                                                        
 
Age   :      Address :                                                                                                                     
 
Gender  :                                                         Date  :                                                                                                             
 
Phone /Mobile No :  
 
Referred by  :     
 
PATIENT HISTORY  
Peripheral artery occlusion :     Unilateral/bilateral : 
 
Fontine stage classification : 
 
Chief complaints : 
 
 
History of present illness: 
1. Cough  
2. Sputum 
3. Dyspnea 
4. Hemoptysis 
 
Past medical history: 
 
 
Surgical history: 
 
 
Personal History: 
1. Smoking 
 Duration : 
 Pack years : 
2. Alcoholic 
 Duration : 
3. Tobacco Chewing 
 
Family History:  
 
Drug history: 
 
Risk factors: 
 
Occupational History: 
 
History of Living Environment:  
 
Previous Functional Status: 
 
Pain History 
Side   : 
Site    : 
Onset   : 
Duration  : 
Type   : 
Aggravating factors  : 
Relieving factors :  
Intensity  : 
 
Vital signs  
Temperature  : 
Heart rate  : 
Blood pressure  : 
Respiratory rate : 
Sao2                                             : 
OBJECTIVE EXAMINATION 
ON OBSERVATION 
Built   :    Posture  : 
Attitude of limbs :    Muscle wasting : 
Gait   :    Edema                         :  
Pressure sore  :    External appliances :  
Tropical changes : 
Clubbing  : 
Cyanosis  :     
Chest wall deformity : 
Breathing pattern : 
 
ON PALPATION 
Palpation of pulses : 
Tone   : 
Edema   : 
Tenderness  : 
Warmth  : 
 
ON EXAMINATION 
1. HIGHER MENTAL FUNCTION 
Level of consciousness  
Orientation 
Person   : 
Place   : 
Time   : 
Immediate  : 
Memory   
Recent    : 
Remote   : 
Attention    :  
Communication   : 
Emotional status   : 
 
2. RANGE OF MOTION FOR LOWER LIMBS 
 RIGHT LEFT 
Hip: 
Flexion 
Extension 
Abduction 
Adduction 
External rotation 
Internal rotation 
  
Knee: 
Flexion 
Extension 
  
Ankle: 
Dorsi flexion 
Plantar flexion 
Inversion  
Eversion 
  
 
 
 
 
 
 
 
 
3.MUSCLE POWER FOR LOWER LIMBS 
 RIGHT LEFT 
Hip: 
Flexors 
Extensors 
Abductors 
Adductors 
External rotators 
Internal rotators 
  
Knee: 
Flexors 
Extensors 
  
Ankle: 
Dorsi flexors 
Plantar flexors 
Invertors 
Evertors 
  
 
4. INTEGUMENTARY 
1.Skin Color 
 
2. Skin Texture  
 
5.CARDIO PULMONARY 
1. Cough 
 
2. Sputum 
 
3. Clubbing 
 
4. Cyanosis 
 
5. Edema 
 
SENSORY INTEGRITY 
Superficial : 
Deep  : 
 
GAIT  
 
ASSISTIVE DEVICES  
 
 
FUNCTIONAL STATUS 
Bed mobility                 : 
Transfer                         : 
ADL                              : 
 
AUSCULTATION 
Breath sounds   : 
 
Added sounds  : 
 
Vocal sounds   : 
 
Heart sounds   : 
 
 
INVESTIGATIONS AND FINDINGS 
 
MEDICAL DIAGNOSIS 
 
PHYSICAL THERAPY DIAGNOSIS 
 
Direct impairments 
 
Indirect impairments 
 
Functional limitations 
 
PHYSIOTHERAPY  MANAGEMENT 
Aims: 
 
Means: 
 
 
Signature of the Principal Investigator 
FOLLOW UP FORM 
 
Patient name:                           O.P.NO: 
Age:                Contact No:                                                                                                 
Sex:                            Date of 1
st
 assessment: 
Occupation:                                                            Date of follow up:                                                                                    
Address: 
Diagnosis: 
Grading: 
Vitals: BP:         mmHg      HR:        bpm      RR:      bpm    Temperature:       deg C 
OUTCOME MEASUREMENTS: 
 
 
S.NO 
 
 
OUTCOME MEASURES 
 
SCORES 
Pre Test 6 
th
 Week Post Test 
(12
th
 Week) 
 
1. 
 
Ankle Brachial Index 
   
2. 
 
 
6 Minute Walk Test 
   
3.  
Walking Impairment 
Questionnaire 
   
 
 
 
Signature of the Primary Investigator 
  
ANNEXURE – III 
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
 
I SUGANYA.M, am carrying out a study on the topic: “Non-mechanized Exercise Training 
to improve pain free walking distance in patients with Peripheral Artery Occlusion”, as 
part of my research project being carried out under the aegis of the Departments of cardio 
thoracic and vascular surgery.   
 
My research guide is: Prof. Mahesh, MPT (Cardio Respiratory) 
 
The justification for this study is:  
Peripheral artery occlusion leads to pain in the calf muscle and walking disability. So non- 
mechanized exercise training can improve peripheral blood circulation, pain free walking 
distance and activities of daily living in patients with peripheral artery occlusion.  
 
The objectives of this study: 
To find out the effect of non-mechanized exercise training to improve pain free walking 
distance in patients with peripheral artery occlusion.  
Sample size: 20 
 
Study volunteers / participants are peripheral artery occlusion patients, age group above 40 
to 65 years 
Location: Department of Cardio Thoracic and vascular surgery, PSG IMS&R Hospitals.  
We request you to kindly cooperate with us in this study. We propose collect background 
information and other relevant details related to this study. We will be carrying out:  
 
Initial interview: 20-30 minutes. 
Final interview: 30 minutes.  
 
Health Education: YES. 
 
 
Clinical examination (specify details purpose): YES 
Blood sample collection: Specify quantity of blood being drawn: ___________ml. NOT 
APPLICABLE 
 
No. of times it will be collected: _______________. NOT APPLICABLE 
 
Whether blood sample collection is part of routine procedure or for research (study) purpose:   
 
1. Routine procedure 2. Research purpose NOT APPLICABLE 
 
Specify purpose, discomfort likely to be felt and side effects, if any: _______NOT 
APPLICABLE ________________________ 
 
Whether blood sample collected will be stored after study period: Yes / No, it will be 
destroyed NOT APPLICABLE 
 
Whether blood sample collected will be sold: Yes / No NOT APPLICABLE 
 
Whether blood sample collected will be shared with persons from another institution: Yes 
/ No NOT APPLICABLE 
 
Medication given, if any, duration, side effects, purpose, benefits: NOT APPLICABLE 
 
Whether medication given is part of routine procedure: Yes / No (If not, state reasons for 
giving this medication) NOT APPLICABLE 
 
Whether alternatives are available for medication given: Yes / No (If not, state reasons for 
giving this medication) NOT APPLICABLE 
 
 
If photograph taken, purpose: yes, without revealing the identity of yours we want to publish 
it in the project book, conferences and journals.  
 
Data collected will be stored for a period of 5 years. We will not use the data as part of 
another study. 
 
Benefits from this study: Performing non-mechanized exercises can reduce the pain in the 
calf muscle which improves the peripheral blood circulation and thereby it improves the 
walking distance. 
 
Risks involved by participating in this study: There are no possible risks or discomforts will be 
experienced during this study.  Patients should take the medications properly at time. If the 
patient feels any discomfort during exercise they can take rest for 10 to 15 minutes and continue the 
exercise. 
How the results will be used:  
Peer-reviewed scientific journals,  
Conference presentation 
Internal report 
The data collected during the study will be used without revealing your identity. Your 
identity will be confidential even if the results of the study are published.  
If you are uncomfortable in answering any of our questions during the course of the 
interview, you have the right to withdraw from the interview / study at anytime. You 
have the freedom to withdraw from the study at any point of time. Kindly be assured that 
your refusal to participate or withdrawal at any stage, if you so decide, will not result in any 
form of compromise or discrimination in the services offered nor would it attract any penalty. 
You will continue to have access to the regular services offered to a patient. You will NOT 
be paid any remuneration for the time you spend with us for this interview / study. The 
information provided by you will be kept in strict confidence. Under no circumstances shall 
we reveal the identity of the respondent or their families to anyone. The information that we 
collect shall be used for approved research purposes only. You will be informed about any 
significant new findings - including adverse events, if any, – whether directly related to you 
or to other participants of this study, developed during the course of this research which may 
relate to your willingness to continue participation.  
 
Consent: The above information regarding the study, has been read by me/ read to me, and 
has been explained to me by the investigator/s. Having understood the same, I hereby give 
my consent to them to interview me. I am affixing my signature / left thumb impression to 
indicate my consent and willingness to participate in this study (i.e., willingly abide by the 
project requirements).  
 
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
 
Signature of the Interviewer with date:    Witness: 
 
 
Contact number of PI: 8220838169 
 
 
 
 
 
 
 
 
 
  
â º¡ §¸¡ ÁÕòÐÅì ¸øæÃ¢ ÁüÚõ ¬Ã¡öîº¢ ¿¢ÚÅÉõ, §¸¡¨Å 
ÁÉ¢¾ ¦¿È¢Ó¨Èì ÌØ 
´ôÒ¾ø ÀÊÅõ 
§¾¾¢: 
Ó. Í¸ýÂ¡, ¬¸¢Â ¿¡ý â º¡ §¸¡ ÁÕòÐÅì ¸øæÃ¢Â¢ý / ÁÕòÐÅÁ¨ÉÂ¢ý þÂýÓ¨È 
ÁÕòÐÅò Ð¨ÈÂ¢ý ¸£ú, “þÂó¾¢Ã ¯¾Å¢Â¢ýÈ¢, þÃò¾ ¿¡Ç «¨¼ôÒ §¿¡ö ¯ûÇÅ÷¸ÙìÌ 
³§º¡§¼¡É¢ì ÀÂ¢üº¢Â¢É¡ø ÅÄ¢Â¢ýÈ¢ ¿¼ìÌõ àÃò¨¾ «¾¢¸ô ÀÎòÐ¾ø ” ±ýÈ ¾¨ÄôÀ¢ø 
¬ö× §Áü¦¸¡ûÇ ¯û§Çý. 
±ý ¬ö× ÅÆ¢¸ ¡ðÊ:  ¾¢Õ. Ã¡. Á§¸‰, Ó¾øÅ÷, â º¡ §¸¡ þÂýÓ¨È ÁÕòÐÅì ¸øæÃ¢ 
¬ö× §Áü¦¸¡ûÅ¾ü¸¡É «ÊôÀ¨¼: 
þÃò¾ ¿¡Ç «¨¼ôÒ §¿¡ö ²üÀÎÅ¾¡ø ¦¸ñ¨¼ì ¸¡ø ¾¨ºÂ¢ø ÅÄ¢ ÁüÚõ ¿¼ì¸ þÂÄ¡¨ Á 
²üÀÎ¸¢ÈÐ. þ¾É¡ø «ýÈ¡¼ Å¡úÅ¢ø ¿¨¼Ó¨È º¡÷ó¾ ¦ºÂø¸û Ì¨È¸¢ÈÐ. þó¾ ¬öÅ¢ø 
þÂó¾¢Ã ¯¾Å¢Â¢ýÈ¢, ¾¨º¸¨Ç ÀÄôÀÎòÐõ ÀÂ¢üº¢ ÁüÚõ ¿¨¼ôÀÂ¢üº¢¸Ç¢ý ãÄõ ¦¸ñ¨¼ì 
¸¡ø ÅÄ¢Â¢¨ É Ì¨ÈòÐ, ÅÄ¢Â¢ýÈ¢ ¿¼ìÌõ àÃò¨¾ «¾¢¸Ã¢ì¸ ÓÂüº¢ì¸ôÀÎ¸¢ÈÐ 
¬öÅ¢ý §¿¡ì¸õ: 
1. ¦¸ñ¨¼ì¸¡ø ÅÄ¢¨ Âì Ì¨Èò¾ø. 
2. ¿¨¼ôÀÂ¢üº¢Â¢É¡ø, ¦ÅÇ¢ôÒÈò ¾¨ºì¸ÙìÌ ¦ºøÖõ þÃò¾ ¶ð¼ò¨¾ «¾¢¸ Ã¢ò¾ø. 
3. «ýÈ¡¼ ¦ºÂøÀ¡Î¸¨Ç «¾¢¸Ã¢ò¾ø 
¬öÅ¢ø ÀíÌ ¦ÀÚõ ¿À÷¸Ç¢ý ±ñ½¢ì¨¸: 20  
¬öÅ¢ø ÀíÌ ¦ÀÚ§Å¡÷ ÁüÚõ ÅÂÐ: 40 - 65 ÅÂÐûÇ þÃò¾ìÌÆ¡ö «¨¼ôÒ §¿¡ö 
¯ûÇÅ÷¸û. 
¬ö× §Áü¦¸¡ûÙõ þ¼õ: þÕ¾Â «Ú¨Åî º¢¸¢î¨º ÁüÚõ þÃò¾ ¿¡Çò Ð¨È, â º¡ §¸¡ 
ÁÕòÐÅÁ¨É, §¸¡ÂõÒòà÷. 
þó¾ ¬öÅ¢ø ±í¸Ù¼ý ´òÐ¨ÆìÌÁ¡Ú §¸ðÎì¦¸¡û¸¢§È¡õ. ¿¡í¸û º¢Ä ¾¸Åø¸¨Ç þó¾ 
¬öÅ¢ü¸¡¸ §º¸Ã¢ì¸ ¯û§Ç¡õ. 
 
¬ö× ¦ºöÂôÀÎõ Ó¨È:  
þó¾ ¬öÅ¢ý ¦Á¡ò¾ ¸¡Ä «Ç× 8 Á¡¾í¸û. þó¾ ¬öÅ¢ø þÃò¾ ÌÆ¡ö «¨¼ôÀ¢É¡ø 
¿¨¼ò¾¢Èý Ì¨ÈÅ¡¸ ¯ûÇ 20 ¿À÷¸Ç¢ø 10 ¿À÷¸¨Çì ¦¸¡ñ¼ þÕ ÌØì¸Ç¡¸ ô À¢Ã¢òÐì 
¦¸¡ûÇôÀÎõ. 
Ó¾ø ÅÕ¨¸Â¢ý §À¡Ð ´ù¦Å¡ÕÅÃ¢ý þÃò¾ìÌÆ¡ö «¨¼ôÀ¢É¡ø, ÅÖì Ì¨Èó¾ ¿¼ì¸ 
þÂÄ¡¨Áì¸¡É §¸ûÅ¢ò¾¡¨Ç (Walking Impairment Questionnaire) ±ýÈ ÀÊÅò¾¢ý 
¯¾Å¢Ô¼ý «ÇóÐ ¦¸¡ûÇôÀÎõ À¢ýÉ÷ (Amkle Brachial Index) ¸Ïì¸¡ø ÒÂ ÌÈ¢Â£Î 
Ó¨ÈÂ¢ý ãÄõ ¿¡ÊÂØò¾ Á¡É¢Â¢É¡ø (Sphygmomanometer) «ÇóÐ ¦¸¡ûÇôÀÎõ.  
À¢ÈÌ 6 ¿¢Á¢¼ ¿¨¼ ¬ö× (6 minutes walk test) ãÄõ ±ùÅÇ× àÃõ ÅÄ¢Â¢ýÈ¢ ¿¼ìÌõ 
àÃò¨¾ «ÇóÐ ¦¸¡ûÇ §ÅñÎõ. 12 Å¡Ãí¸û «Å÷¸ÙìÌ, ¾Â¡÷ ¿¢¨Äì¸¡É ÀÂ¢üº¢¸û 
(warm up Exercise) ¾¨º¸¨Ç ÅÖôÀÎòÐõ ÀÂ¢üº¢¸û (Muscle Strengthening 
Exercise) ¾Ç÷× ¿¢¨ Äô ÀÂ¢üº¢¸û (Cool Down Exercise) ¿¨¼ôÀÂ¢üº¢¸ û (Walking 
Exercise) ¬¸¢Ô¨Å¸¨Ç ¯ûÇ¼ì¸¢Â ÐñÎô À¢ÃÍÃõ (Phamplet) «Ç¢ì¸ôÀÎõ. 
À¢ýÉ÷ 12 Å¡Ãí¸ÙìÌ À¢ÈÌ, ÅÖìÌ¨Èó¾ ¿¼ì¸ þÂÄ¡¨Áì¸¡É §¸ûÅ¢ôÀÊÅõ (walking 
Impairment Questionnaire) ¸Ïì¸¡ø ÒÂ ÌÈ¢Â£Î (Ankle Brachial Index) 6 ¿¢Á¢¼ 
¿¨¼ ¬ö× (6 minutes walk test) ¬¸¢Â¨Å¸û «ÇÅ¢¼ôÀÎõ. 
 
Ó¾ý¨Á §¿÷¸¡½ø: 20-30 ¿¢Á¢¼í¸û 
ÓÊ× §¿÷¸¡½ø: 30 ¿¢Á¢¼í¸û  
þó¾ ¬öÅ¢ø ¸¢¨¼ìÌõ ¾¸Åø¸û 5 ÅÕ¼í¸û À¡Ð¸¡ì¸ôÀÎõ. þó¾ ¾¸Åø¸û §ÅÚ 
¬öÅ¢üÌô ÀÂýÀÎò¾ô À¼ Á¡ð¼¡Ð. 
 
Í¸¡¾¡Ãì ¸øÅ¢: «Á÷×¸û: 1 Ó¨È, 12 Å¡Ãí¸û, Å£ðÊÄ¢Õó§¾ ÀÂ¢üº¢¸¨Ç ¸¨¼ôÀ¢Êì¸ 
§ÅñÎõ. 
ÁÕòÐÅ ÀÃ¢§º¡¾¨É¸û: ¯ñÎ 
þÃò¾ Á¡¾¢Ã¢ §º¸Ã¢ôÒ: þø¨Ä 
þÃò¾ Á¡¾¢Ã¢ ±ÎôÀÐ ÅÆì¸Á¡É º¢¸¢î¨ºì¸¡¸§Å¡ «øÄÐ þó¾ ¬öÅ¢ü¸¡¸§Å¡:  
¦À¡Õó¾¡Ð 
þ¾É¡ø ²üÀ¼ì ÜÊÂ «¦ºª¸Ã¢Âí¸û / Àì¸ Å¢¨Ç×¸û: ¦À¡Õó¾¡Ð 
þÃò¾ Á¡¾¢Ã¢¸û ¬öÅ¢üÌô À¢ý À¡Ð¸¡òÐ ¨Åì¸ôÀÎÁ¡? ¬õ / þø¨Ä, «Æ¢ì¸ôÀÎõ: 
¦À¡Õó¾¡Ð 
§º¸Ã¢ì¸ôÀð¼ þÃò¾õ Å¢ü¸ôÀÎÁ¡? ¬õ / þø¨Ä ¦À¡Õó¾¡Ð 
§º¸Ã¢ì¸ôÀð¼ þÃò¾õ §ÅÚ ¿¢ÚÅÉòÐ¼ý À¸¢÷óÐ ¦¸¡ûÇôÀÎÁ¡? ¬õ / þø¨Ä: ¦À¡Õó¾¡Ð 
ÁÕóÐ¸û ²§¾Ûõ ¦¸¡Îì¸ôÀ¼Å¢Õó¾¡ø «¨Å ÀüÈ¢Â Å¢ÅÃõ (¦¸¡Îì¸ôÀÎõ ¸¡Ã½õ, ¸¡Äõ, 
Àì¸ Å¢¨ Ç×¸û, ÀÂý¸û): ¦À¡Õó¾¡Ð 
 
ÁÕóÐ¸û ¦¸¡Îì¸ôÀÎÅÐ ÅÆì¸Á¡É º¢¸¢î¨º Ó¨ÈÂ¡?:  ¬õ / þø¨Ä (þø¨Ä ±ýÈ¡ø 
¦¸¡Îì¸ôÀÎõ ¸¡Ã½õ) ¦À¡Õó¾¡Ð 
 
¦¸¡Îì¸ôÀÎõ ÁÕóÐ¸ÙìÌ Á¡üÚ ¯ûÇ¾¡?: ¬õ / þø¨Ä (¬õ ±ýÈ¡ø þó¾ ÌÈ¢ôÀ¢ð¼ 
ÁÕóÐ ¦¸¡Îì¸ôÀÎõ ¸¡Ã½õ) ¦À¡Õó¾¡Ð 
 
¬öÅ¢ø ÀíÌ¦ÀÚÅ¾¡ø ²üÀÎõ ÀÄý¸û:  
1. ¦¸ñ¨¼ì¸¡ø ÅÄ¢ Ì¨ÈÔõ. 
2. ÅÖì Ì¨ÈÅ¢É¡ø ¿¼ì¸ þÂÄ¡¨Á¨Â ¿¨¼ôÀÂ¢üº¢ ¦ºöÅ¾¡ø þÃò¾ ¶ð¼õ 
«¾¢¸ Ã¢òÐ, ¿¼ìÌõ àÃõ «¾¢¸ Á¡Ìõ. 
¬öÅ¢ø Àí§¸üÀ¾¡ø ²üÀÎõ «¦ºª¸Ã¢Âí¸û / Àì¸ Å¢¨Ç×¸û: þó¾ ¬öÅ¢É¡ø ¾í¸ÙìÌ 
±ó¾ Å¢¾Á¡É «À¡Âí¸Ùõ «¦ºÇ¸Ã¢Âí¸Ùõ ²üÀ¼¡Ð. ºÃ¢Â¡É §¿Ãò¾¢ø ÁÕóÐ¸¨Ç 
¯ð¦¸¡ûÇ §ÅñÎõ. ÀÂ¢üº¢Â¢ý §À¡Ð ²¦¾Ûõ «¦ºÇ¸Ã¢Âí¸û ²üÀð¼¡ø ÀÂ¢üº¢¨ Â 10-20 
¿¢Á¢¼í¸û ¿¢Úò¾¢Å¢ðÎ º¢È¢Ð §¿Ã ¶öÅ¢üÌ À¢ý ¦¾¡¼ÃÄ¡õ. 
¬öÅ¢ý ÓÊ×¸û ±ó¾ Ó¨ÈÂ¢ø ÀÂýÀÎò¾ôÀÎõ? 
«¸¿¢¨ Ä «È¢ì¨¸, ¸Äó¾¡ö×¸Ç¢ø ºÁ÷ôÀ¢ôÒ, ¯½÷× ¬üÈø, Àò¾¢Ã¢ì¨¸¸û ¬öÅ¢ø º¡÷ó¾ 
¬Ã¡öîº¢ Àò¾¢Ã¢ì¨¸¸û. 
 
þó¾ ¬öÅ¢ý §¸ûÅ¢¸ ÙìÌ À¾¢ÄÇ¢ôÀ§¾¡, þÃò¾ Á¡¾¢Ã¢¸û «øÄÐ ¾¢Í Á¡¾¢Ã¢¸û 
±ÎôÀ¾¢§Ä¡ ¯í¸ÙìÌ ²§¾Ûõ «¦ºÇ¸Ã¢Âí¸û þÕó¾¡ø, ±ó¾ §¿Ãò¾¢ø §ÅñÎÁ¡É¡Öõ 
¬öÅ¢Ä¢ÕóÐ Å¢Ä¸¢ì¦¸¡ûÙõ ¯Ã¢¨ Á ¯í¸ÙìÌ ¯ñÎ. ¬öÅ¢Ä¢ÕóÐ Å¢Ä¸¢ì¦¸¡ûÅ¾¡ø 
¯í¸ÙìÌ «Ç¢ì¸ôÀÎõ º¢¸ ¢î¨º Ó¨ÈÂ¢ø ±ó¾ Å¢¾ À¡¾¢ôÒõ þÕì¸¡Ð ±ýÚ ¯í¸ÙìÌ 
¯Ú¾¢ÂÇ¢ì¸¢§È¡õ. ÁÕòÐÅ Á¨ÉÂ¢ø §¿¡Â¡Ç¢¸ÙìÌ «Ç¢ì¸ôÀÎõ §º¨Å¸¨Ç ¿£í¸û 
¦¾¡¼÷óÐ ¦ÀÈÄ¡õ. þó¾ ¬öÅ¢ø Àí§¸ü¸  ´ôÒì¦¸¡ûÙÅ¾¡ø §ÅÚ ±ó¾ Å¢¾Á¡É 
ÜÎ¾Ä¡É ÀÄÛõ ¯í¸ÙìÌì ¸¢¨¼ì¸¡Ð. ¿£í¸û «Ç¢ìÌõ ¾¸Åø¸û þÃ¸º¢ÂÁ¡¸ 
¨Åì¸ôÀÎõ. ¬öÅ¢ø Àí§¸ üÀÅ÷¸ û ÀüÈ¢§Â¡ «Å÷¸û ÌÎõÀò¨¾ô ÀüÈ¢§Â¡ ±ó¾ò ¾¸ÅÖõ 
±ì¸¡Ã½õ ¦¸¡ñÎõ ¦ÅÇ¢Â¢¼ôÀ¼¡Ð ±ýÚ ¯Ú¾¢ÂÇ¢ì¸¢§È¡õ. ¿£í¸û «Ç¢ìÌõ ¾¸Åø¸û / 
þÃò¾ Á¡¾¢Ã¢¸û / ¾¢Í Á¡¾¢Ã¢¸û «í¸£¸Ã¢ì¸ôÀð¼ ¬öÅ¢üÌ ÁðÎ§Á ÀÂýÀÎò¾ôÀÎõ. þó¾ 
¬ö× ¿¨¼¦ÀÚõ ¸¡Äò¾¢ø ÌÈ¢ôÀ¢¼ò¾Ìó¾ Ò¾¢Â ¸ñÎÀ¢ÊôÒ¸û «øÄÐ Àì¸ Å¢¨ Ç×¸û 
²Ðõ ²üÀð¼¡ø ¯í¸ÙìÌò ¦¾Ã¢Å¢ì¸ôÀÎõ. þ¾É¡ø ¬öÅ¢ø ¦¾¡¼÷óÐ ÀíÌ ¦ÀÚÅÐ 
ÀüÈ¢Â ¯í¸û ¿¢¨ÄôÀ¡ð¨¼ ¿£í¸û ¦¾Ã¢Å¢ì¸ ²ÐÅ¡Ìõ. 
 
¬ö×ìÌðÀÎÀÅÃ¢ý ´ôÒ¾ø: þó¾ ¬ö¨Åô ÀüÈ¢Â §ÁüÜÈ¢Â ¾¸Åø¸¨Ç ¿¡ý ÀÊòÐ 
«È¢óÐ ¦¸¡ñ§¼ý / ¬öÅ¡Ç÷ ÀÊì¸ì §¸ðÎò ¦¾Ã¢óÐ ¦¸¡ñ§¼ý. ¬öÅ¢¨ Éô ÀüÈ¢ 
¿ýÈ¡¸ô ÒÃ¢óÐ ¦¸¡ñÎ þó¾ ¬öÅ¢ø ÀíÌ ¦ÀÈ ´ôÒì¦¸¡û¸¢§Èý. þó¾ ¬öÅ¢ø 
Àí§¸üÀ¾ü¸¡É ±ÉÐ ´ôÒ¾¨Ä ¸£§Æ ¨¸¦Â¡ôÀÁ¢ðÎ, ¨¸ §Ã¨¸ À¾¢òÐ ¿¡ý ¦¾Ã¢Å¢òÐì 
¦¸¡û¸¢§Èý. 
 
Àí§¸üÀ¡ÇÃ¢ý ¦ÀÂ÷, Ó¸ÅÃ¢: 
 
Àí§¸üÀ¡ÇÃ¢ý ¨ ¸¦Â¡ôÀõ / ¨¸ §Ã¨¸ / ºð¼ôâ÷Å À¢Ã¾¢¿¢¾¢Â¢ý ¨¸¦Â¡ôÀõ: 
 
§¾¾¢ : 
  
¬öÅ¡ÇÃ¢ý ¨ ¸¦Â¡ôÀõ: 
§¾¾¢  : 
 
¬öÅ¡ÇÃ¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 8220838169 
ÁÉ¢¾ ¦¿È¢Ó¨Èì ÌØ «ÖÅÄ¸ò¾¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 0422-4345818 
 
ANNEXURE – IV 
OUTCOME MEASURES 
 
WALKING IMPAIRMENT QUESTIONNAIRE 
The WIQ measures walking distance, walking speed and stair climbing in the 
community. For walking distance, the participant ranks his or her degree of difficulty walking 
specific distances on a 0 to 4 Likert scale, where 0 represents inability to walk the distance 
and 4 represents no difficulty. Distances range from walking indoors around the home to 
walking five blocks (1,500 feet). For walking  speed, the participant ranks the degree of 
difficulty walking slowly, at average speed, quickly, or running or jogging one block .In the 
stair climbing component, patients rank their ability to walk up and down one, two or three 
flights of stairs respectively. 
SCORING THE WALKING IMPAIRMENT QUESTIONNAIRE 
In the stair climbing component, each distance expressed as “feet”   is multiplied by 
the Likert score selected for that distance. Products are summed and divided by the maximum 
possible score to obtain the percentage score. similar percentage scores are obtained for the 
walking speed and stair climbing WIQ components. For the walking speed component, each 
speed is given a “weight,” ranging from 1 mile per hour to 5 miles per hour, which is 
multiplied by the Likert scale response. In the stair climbing component each stair climbing 
category is weighted according to the number of stairs in each category.  
 
 
 
 
 
 
 
 
 
 
ANKLE-BRACHIAL INDEX 
A Diagnostic Tool for Peripheral Arterial Disease 
Step-by-step instructions on how to perform and interpret the ABI  
ABI: 
The ankle-brachial index (ABI) is a simple, noninvasive tool used to screen for peripheral 
arterial disease (PAD), a vascular condition affecting more than 8 million adult Americans 
and associated with significant morbidity and mortality. Despite its prevalence and 
cardiovascular risk implications, only 25% of PAD patients are undergoing treatment. As 
only about 10% of patients with PAD present with classic claudication-40% of patients are 
asymptomatic clinicians need to have a high level of suspicion for this disease in their adult 
patient population. According to AHA/ACC guidelines, an ABI should be conducted on 
patients presenting with risk factors for PAD so that therapeutic interventions known to 
diminish their increased risk of myocardial infarction (MI), stroke, and death may be offered.  
 
Risk Factors for PAD 
 
 Age >70 years 
 Age >50 years if atherosclerosis risk 
 Smoking 
 Diabetes 
 Hypertension 
 Dyslipidemia   
 Hyperhomocysteinemia 
Tools Needed for Measuring ABI 
 Sphygmomanometer with appropriately sized cuff(s) for both arm and ankle  
 Handheld Doppler device with vascular probe  
 Conductivity gel compatible with the Doppler device  
 
How to perform the ABI 
Measurement of the ABI can be easily performed in a clinician‟s office using a blood 
pressure (BP) cuff and handheld Doppler device with a vascular probe. Systolic BP is 
determined in both arms and both ankles. An ABI measurement can usually be performed in 
less than 10 minutes.  
 Step 1: Measure the brachial systolic pressure in both arms: 
 Allow patient to rest for 5-10 minutes in the supine position.  
 Place the BP cuff on patient‟s upper arm with the lower edge approximately 1 inch 
above the antecubital fossa.  
 Palpate for the brachial pulse and apply conductivity gel over the brachial artery. 
Place the tip of the probe into the gel at a 45-60-degree angle until clear arterial pulse 
sounds are heard.  
 Inflate the cuff to the point that pulse sounds disappear, then go 20 mm Hg above that 
point. Slowly deflate at a rate of 2 mm Hg per sec and record the point where arterial 
pulse sounds resume. This is the brachial systolic pressure.  
  Repeat this procedure in the other arm.  
 The higher of the two brachial systolic pressure readings will be used to calculate the 
ABI. There should be a difference of a less than 10mm Hg. Between each brachial 
BP. 
Step 2: Measure the posterior tibial and dorsalis pedis systolic pressures in 
both legs:  
 Place the BP cuff on the patient‟s leg approximately 2 inches above the ankle‟s 
medial malleolus.  
 Locate the posterior tibial (PT) pulse, apply gel, and position the Doppler probe. 
Measure the systolic pressure following the same procedure described for the 
brachial artery.  
 On the same leg, locate the dorsalis pedis (DP) pulse and measure systolic 
pressure.  
 Repeat measurement of both the PT and DP systolic pressures on the other leg. 
 Select the higher of the two ankle readings for each leg (PT or DP). These 
numbers will serve as the ankle systolic pressures in the ABI calculation.  
 If either the PT or DP ankle pulse is absent, use the measurable reading to 
calculate the ABI.  
Step 3: To calculate the ABI, divide each ankle systolic pressure by the 
brachial systolic pressure.  
 Divide the higher of the two systolic pressures for each leg by the higher of the 
two arm pressures to get the right and left ABI. 
 For example, consider the results at the right. The ABI for this patient is 
calculated by using 130 (the higher of the two brachial pressures) as the 
denominator and 95 and 130 as the numerators for the right and left legs, 
respectively. The ABI for the right leg is 0.73 and for the left leg is 1.0.  
 
ABI RESULTS 
 
SYSTOLIC PRESSURE RIGHT LEFT 
Brachial 130 129 
Posterior Tibial 95 120 
Dorsalis Pedis 90 130 
ABI= Ankle systolic/brachial systolic 
 95/130 130/130 
ABI 0.73 1.0 
 
 
ABI Key  
Normal: 1.0 - 1.1  
Borderline: 0.91 - 0.99  
Abnormal: <0.9 or >1.3 
How to interpret the ABI 
An abnormal ABI may be an independent predictor of mortality, as it reflects the 
burden of atherosclerosis. Most will agree that a normal ABI is >0.9. An ABI <0.9 suggests 
significant narrowing of one or more blood vessels in the leg. The majority of patients with 
claudication have ABIs ranging from 0.3 to 0.9. Rest pain or severe occlusive disease 
typically occurs with an ABI <0.5. ABIs <0.2 are associated with ischemic or gangrenous 
extremities. Conditions such as diabetes mellitus or end stage-renal disease can give falsely 
elevated ABIs (1.3-1.5). The ABI test approaches 95% accuracy in detecting PAD. However, 
a normal ABI value does not absolutely rule out the possibility of PAD. Some patients with 
normal or near-normal ABI results may have symptoms suggesting PAD. If the resting ABI 
is normal, an exercise ABI should be conducted.  
Six-minute walk test 
Each patient was administered 6 min walk test pain free walking distance measurements were 
taken thrice within 12 weeks. Two cones were placed 30 meters apart in a marked corridor.  
Patients were instructed to walk as many laps around the cones as possible and to inform the 
therapist when the claudication occurred. patients were permitted to stop walking during the 
test if their claudication becomes intolerable,  but the time continued to run during the period. 
Patients who stopped walking because of claudication pain were encouraged to continue 
walking as soon as possible. The therapist  recorded the total distance walked and calculate 
the pain free walking distance. 
SIX MINUTE WALK TEST ASSESSMENT SHEET 
 
Patient Name:       Date  : 
Age/ Sex  :       OP No : 
Diagnosis     :        
 
Total distance walked        : 
 
Pain free walking distance : 
 
Claudication  Pain begins : 
 
 
 
Therapist Signature: 
 
 
ANNEXURE – V 
TREATMENT PROTOCOL 
GROUP A- MEDICATIONS ALONG WITH ROUTINE MANAGEMENT 
(CONVENTIONAL MANAGEMENT): 
1. Medications along with deep breathing Exercise. 
2. Active Range of motion exercise to lower limbs. 
3. General Walking 
4. Do‟s and Don‟s  advised. 
Group B: 
Exercise Instructions: 
1. Record your heart rate while exercising 
2. Gradually increase the intensity and duration of exercise 
3.Exercise which includes (warm up, isotonic exercises, walking program, cool 
down) 
4. Exercise should be stop when if you feel discomfort or any these problems 
(breathing difficulty, chest pain,  palpitation ,leg pain ,excessive  sweating, 
giddiness) 
Precaution
(13)
: 
1.Avoid restrictive clothing which may interfere with the circulation. eg. tight 
belts. 
2.Stop Smoking and alcoholic or reduce as much as possible. 
3. Avoid prolonged standing. 
4. Avoid exposure to excessive heat or cold or take care with the application of 
heat. eg. hot water bottles. 
5. A gradual return to normal function and increasing the amount of physical 
activity. 
 
Exercise prescription: 
Endurance training: 
      Frequency : 1 hour per day, 3days per week for 12 weeks 
      Intensity    : Based on the karvonen formula 
      Duration     : walking as per chart. 
       Type         : Aerobic Exercise ( Ground walking).   
Resistance training: 
    Frequency : 1 hour per day, 3days per week for 12 weeks  
    Intensity    : Based on the RM (Repetition maximum). 
    Duration    : 30 to 60 minutes. 
    Type          : Isotonic Exercise. 
 
Example training heart rate zone 
For example, 25 year old male who has resting heart rate of 65, want to know 
his  resting heart rate for the intensity level 60% to 70%. 
His Minimum Heart Rate: 
      220-25(age) =195 
      195-65(Resting Heart Rate)=130 
      130*0.60(Minimum Intensity)+65(Resting Heart Rate)=143 Beats/Minute  
His Maximum Heart Rate: 
      220-25(age)=195 
     195-65(Resting Heart Rate)=130 
      130*0.70(Minimum Intensity)+65(Resting Heart Rate)=156 Beats/Minute 
His training heart rate zone will therefore be 143-156 beats per minute. 
Repetition Maximum Calculation For Lower Body 
= (4-6Rm * 1.097 03) + 14.2546 
According to Epley formula=1 RM=w ( 1+r/30)  r>1 
Training Programs
(1)
: 
 Frequency of training: 
A training frequency increases to 3 days per week for 12 weeks.  
Duration of training: 
         Training session duration has varied from 10 to 60 minutes.  
Work to rest ratios : 
Patients with PAD engage in intermittent training where patients walk encounter ,stop to rest 
and once claudication pain subsides, resume walking. 
Resistance Training
(1)
: 
 Exercise training began with 5 minutes of warm up and 5 minutes of cool down. Subjects to 
train for 60 minutes, three times a week for 12 weeks. subjects performed concentric 
contractions of five different muscle groups in legs at a resistance that caused fatigue after six 
contractions muscles including the gastrocnemius, tibialis anterior, quadriceps femoris, 
hamstrings and gluteus maximus were trained in this manner. The resistance to the muscle 
contraction was applied by attaching weight cuffs using sand to appropriate location on the 
leg. A six repetition maximum was assessed every 2 weeks and training intensity was altered 
accordingly by increasing the resistance.  
Isotonic exercise : 
Type Of Exercise: Isotonic Exercises. 
Equipment : ½ Kg Sand Bags For 2weeks. 
Progression: It depends on the Repetition Maximum 12 weeks after target 6 to 8 
Repetitions. 
  
1.Target Muscle:Gluteus Maximus 
Action : Hip Extension 
 
2.Target Muscle :Hamstring 
Action : Knee Flexion 
 
.3.Target Muscle : Quadriceps 
     Action : Extension of  the knee joint.  
 
4. Target Muscle : Tibialis anterior 
 Action :Dorsi flexion and inversion of the ankle.  
 
5.Target Muscle : Gastronemius 
 Action : Flexion of the knee joint& Plantar flexion at the ankle joint.  
 
. Walking program
(8)
 : 
The walking time started with 20 minutes in the first two weeks of the program. After two 
weeks, It increased by 5 minutes biweekly. In the last two weeks of the study, the walking 
time was 40-45 minutes.  
 
Weeks Warm up Walking Cool Down 
week 1 5 minutes 20 minutes 5 minutes 
week  2 5 minutes 20 minutes 5 minutes 
week  3 5 minutes 25 minutes 5 minutes 
week  4 5 minutes 25 minutes 5 minutes 
week  5 5 minutes 30 minutes 5 minutes 
week  6 5 minutes 30 minutes 5 minutes 
week  7 5 minutes 35 minutes 5 minutes 
week  8 5 minutes 35 minutes 5 minutes 
week  9 5 minutes 40 minutes 5 minutes 
week 10 5 minutes 40 minutes 5 minutes 
week 11 5 minutes 45 minutes 5 minutes 
week 12 5 minutes 45 minutes 5 minutes 
 
ANNEXURE – VI 
PRE TEST AND POST TEST VALUES FOR ABI IN GROUP-A - (n=10) 
 
S.NO 
ABI 
PRE TEST 
ABI 
POST TEST 
1. 0.54 0.83 
2. 0.50 0.86 
3. 0.61 0.81 
4. 0.66 0.80 
5. 0.69 0.84 
6. 0.58 0.88 
7. 0.60 0.80 
8. 0.59 0.83 
9. 0.70 0.87 
10. 0.77 0.89 
 
 
PRE TEST AND POST TEST VALUES FOR ABI IN GROUP-B - (n=10) 
 
S.NO 
ABI 
PRE TEST 
ABI 
POST TEST 
1. 0.55 0.94 
2. 0.50 0.99 
3. 0.62 0.91 
4. 0.67 0.93 
5. 0.70 0.90 
6. 0.59 0.95 
7. 0.61 0.96 
8. 0.60 0.92 
9. 0.71 0.97 
10. 0.78 0.94 
 
  
PRE TEST AND POST TEST VALUES FOR 6MWT PAIN FREE 
WALKING DISTANCE IN GROUP-A 
(n=10) 
S.NO 6MWT 
PRE TEST 
6MWT 
POST TEST 
1. 70 120 
2. 120 165 
3. 125 195 
4. 240 255 
5. 130 210 
6. 95 90 
7. 100 210 
8. 105 240 
9. 150 210 
10. 170 210 
*6MWT Distance calculated in Percentage 
 
 
  
PRE TEST AND POST TEST VALUES FOR 6MWT PIN FREE 
WALKING DISTANCE  IN GROUP-B 
(n=10) 
S.NO 6MWT 
PRE TEST 
6MWT 
POST TEST 
1. 240 390 
2. 155 335 
3. 100 210 
4. 45 125 
5. 210 390 
6. 220 285 
7. 125 270 
8. 105 240 
9. 160 315 
10. 90 95 
     *6MWT Distance calculated in Percentage 
 
 
  
PRE TEST AND POST TEST VALUES FOR WIQ  IN GROUP-A (n=10) 
S.NO WIQ SCORE 
PRE TEST 
WIQ SCORE 
POST TEST 
1. 26 32 
2. 25 31 
3. 30 41 
4. 21 26 
5. 19 21 
6. 15 28 
7. 32 40 
8. 25 33 
9. 25 35 
10. 25 38 
 
  
PRE TEST AND POST TEST VALUES FOR WIQ  IN GROUP-B -(n=10) 
S. NO WIQ SCORE 
PRE TEST 
WIQ SCORE 
POST TEST 
1. 22 46 
2. 13 39 
3. 15 45 
4. 29 53 
5. 21 52 
6. 27 44 
7. 31 50 
8. 23 43 
9. 21 53 
10. 34 39 
 
 
 
 
  
ABSTRACT 
NON-MECHANIZED EXERCISE TRAINING TO IMPROVE PAIN FREE 
WALKING DISTANCE IN PATIENTS WITH PERIPHERAL ARTERY 
OCCLUSION 
 
BACKGROUND Peripheral arterial disease (PAD) is most commonly defined as gradual obstruction 
of arteries leading to impaired blood flow. The prevalence of PAD increase with aging, in general 
population it accounts for  12% to 14 % affecting up to 25% of subjects over 75 years. Intermittent 
claudication is the pain in lower limbs during walking, which forces the person to stop walking. 
Superficial femoral and popliteal arteries are most commonly affected by atherosclerosis.  It is 
associated with increased mortality, major limitations in mobility, physical conditioning and 
decreased quality of life. Non-mechanized exercise training is a form of exercise programme without 
using any mechanical equipments helping to improve blood flow in the peripheral arteries of the 
lower extremities. 
Objective: To find out the effects of non-mechanized exercise training in improving  pain free 
walking distance in patients with peripheral artery occlusion.  
Design: Pre- test-Post- test Quasi experimental study design.  
Setting: Department of  Cardio thoracic and Vascular Surgery, P.S.G hospitals, Coimbatore. 
Participants: 
Group-A: 10 patients received medications along with routine management (conventional 
management)  
Group-B: 10 patients received medications along with the non-mechanized exercise training that is 
structured. 
Intervention:  
Group-A: medications with active exercise 10 repetitions per day, 3 days for week for                     
continued for 12 weeks. 
Group-B: medications with non-mechanized exercise training for 10 repetitions per                                
day, 3 days for week for continued for 12 weeks.  
Outcome Measures: Ankle Brachial Index.(ABI). 
Six Minute Walk Test (6MWT). 
Walking Impairment Questionnaire (WIQ). 
Results: All participants in Group-A and Group-B showed significant improvement in ABI  scores 
with a mean difference of 0.207 and 0.308 respectively. The calculated „t‟ value using the paired „t‟ 
test for Group A 8.714 which was greater than the table value of 2.262 at p<0.05  and B were 10.145 
(p<0.05) respectively. In 6MWT distance Group-A and Group-B showed significant improvement 
with a mean difference of 60 and 120.50 respectively. The calculated „t‟ value using the paired „t‟ test 
for Group-A and B were 4.557 and 6.817 (p<0.05) respectively. In WIQ scores Group-A and Group-B 
showed significant improvement with a mean difference of 6.2 and 22.8   respectively. The calculated 
„t‟ value using the paired „t‟ test for group A and B were 7.235 and 8.908 (p<0.05) respectively. When 
comparing between the groups using independent „t‟ test, the ABI scores showed mean difference of 
1.00 and „t‟ value of 7.368 (p<0.05) ,6MWT distance showed mean difference of 75.00 and „t‟ value 
of 2.097 (p>0.05) and WIQ scores showed mean difference of 13.90 and „t‟ value of 5.284 (p<0.05). 
Conclusion: There was statistically significant improvement in ABI and WIQ. when comparing two 
groups  there was no significant changes in  6MWT pain free walking distance in patients with 
peripheral artery occlusion following Non-mechanized exercise training than conventional training.  
 
Keywords: Ankle Brachial Index, Walking Impairment Questionnaire, Peripheral Artery Disease, Six 
Minute Walk Test 
